Previous 10 | Next 10 |
Edwards Lifesciences Corporation (NYSE:EW) traded today at a new 52-week high of $114.22. Approximately 2.3 million shares have changed hands today, as compared to an average 30-day volume of 2.5 million shares. In the past 52 weeks, shares of Edwards Lifesciences Corporation have traded...
Image source: The Motley Fool. Edwards Lifesciences Corporation (NYSE: EW) Q2 2021 Earnings Call Jul 29, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: Edwards Lifesciences Corporation (EW) Q2 2021 Earnings Call Tr...
Fisher’s 13F portfolio value increased from ~$142B to ~$159B in Q2 2021. The Vanguard Intermediate-Term Corporate Bond ETF stake was increased substantially this quarter. The top three positions are Apple, Microsoft, and Amazon. They add up to ~14% of the portfolio. F...
Edwards Lifesciences Corporation (EW) Q2 2021 Earnings Conference Call July 29, 2021 5:00 PM ET Company Participants Mark Wilterding - President, Investor Relations Mike Mussallem - Chairman and Chief Executive Officer Scott Ullem - Chief Financial Officer Conference Call Participants Bob Hop...
Edwards Lifesciences (NYSE:EW): Q2 Non-GAAP EPS of $0.64 beats by $0.09; GAAP EPS of $0.78 beats by $0.28. Revenue of $1.38B (+49.2% Y/Y) beats by $100M. TAVR sales exceeded expectations and grew 52 percent; underlying sales grew 48 percent. Continued progress on five pivotal trials in TMTT. ...
Edwards Lifesciences presents with the economic pillars that round out a robust investment case. Central to the sell-side's thesis is EW's valuation, which we firmly believe is justified at 46X earnings and 36X EBITDA. EW isn't the same business it was 2 or even 5 years ago, there...
Study Data Presented at TVT on the Economics of Minimalist TAVR, PARTNER 3 Bicuspid TAVR PR Newswire IRVINE, Calif. , July 22, 2021 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today announced that clinical and economic results from the 3M (multidisci...
Edwards Lifesciences To Host Earnings Conference Call On July 29, 2021 PR Newswire IRVINE, Calif. , July 22, 2021 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended June 30, 2021 after the market...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Demand for medical devices and equipment is rebounding following a pandemic-led decline last year as people deferred elective surgeries. This, coupled with their integration of advanced technologies and successful entry in new market segments, we think positions Intuitive (ISRG), Stryker (SYK...
News, Short Squeeze, Breakout and More Instantly...
Edwards Lifesciences Corporation Company Name:
EW Stock Symbol:
NYSE Market:
Edwards Lifesciences Corporation Website:
Vancouver, British Columbia--(Newsfile Corp. - July 30, 2024) - East West Petroleum Corp. (TSXV: EW) ("East West" or the "Company") is pleased to provide this update in regard to the status of the proposed return of capital announced on June 19, 2024 . The Company has prepared and mailed its ...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 1.7% to $112.28 on volume of 455,296,152 shares Ford Motor Company (F) fell 18.4% to $11.16 on volume of 256,384,806 shares PROSHARES TRUST (SQQQ) rose 3.4% to $9.37 on volume of 246,885,889 shares Sel...
2024-07-25 16:00:08 ET Pito Chickering from Deutsche Bank issued a price target of $85.00 for EW on 2024-07-25 13:36:00. The adjusted price target was set to $85.00. At the time of the announcement, EW was trading at $60.58. The overall price target consensus is at $109....